SCHEMBL7375950

SCHEMBL7375950

CC1CN(Cc2ccc(C#N)c(NC(c3ccccc3)c3ccccc3)c2)C(=O)C(C)N1C(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 6/20 0.49
CACNA1H O95180 6/20 0.49
CACNA1I Q9P0X4 6/20 0.49
HTR2C P28335 1/20 0.39
PTGDR2 Q9Y5Y4 2/20 0.34
CTSL P07711 1/20 0.34
CTSS P25774 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AGTR2 P50052 3/20 0.34
CHRM2 P08172 2/20 0.34
CHRM1 P11229 1/20 0.34
PGR P06401 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HCRTR2 O43614 1/20 0.33
PDK1 Q15118 1/20 0.33
PDK2 Q15119 1/20 0.33
PDK3 Q15120 1/20 0.33
PDK4 Q16654 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4388057 1.00 CACNA1G (0.49) CACNA1GCACNA1HCACNA1IHTR2CPTGDR2
SCHEMBL4388052 1.00 CACNA1G (0.49) CACNA1GCACNA1HCACNA1IHTR2CPTGDR2
SCHEMBL5789808 0.89 CACNA1G (0.36) CACNA1GCACNA1HCACNA1ICHRM2CHRM1
SCHEMBL4399774 0.84 CACNA1G (0.54) CACNA1GCACNA1HCACNA1IHTR2CPTGDR2
SCHEMBL4399779 0.84 CACNA1G (0.54) CACNA1GCACNA1HCACNA1IHTR2CPTGDR2
SCHEMBL4392712 0.70 CACNA1I (0.54) CACNA1GCACNA1HCACNA1IHTR2C
SCHEMBL4388098 0.70 CACNA1I (0.52) CACNA1GCACNA1HCACNA1IHTR2C
SCHEMBL4543009 0.70 CACNA1I (0.54) CACNA1GCACNA1HCACNA1IHTR2C
SCHEMBL4388104 0.70 CACNA1I (0.52) CACNA1GCACNA1HCACNA1IHTR2C
SCHEMBL4387155 0.69 CACNA1G (0.53) CACNA1GCACNA1HCACNA1IHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051176-A4 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARM PROD INC (US) 2002-06-12 EP disclosed
EP-1051176-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS Aventis Pharmaceuticals Products Inc. (US) 2000-11-15 EP disclosed
WO-2000032590-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 2000-06-08 WO disclosed
WO-1999037304-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-07-29 WO disclosed